STAT+: Lilly’s breast cancer combo wins approval

AI Summary

The US FDA has approved a new combination drug treatment for patients with advanced breast cancer, marking a significant advancement in treatment options for this disease. This approval represents progress in pharmaceutical therapies for serious health conditions.

The FDA just approved a new combination drug treatment for patients with an advanced form of breast cancer.